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Introduction
Man is in a continuous battle with emerging and re-
emerging diseases. In past, the incidence of these 
diseases in humans has increased and threatens to 
increase in future. The number of reported outbreaks 
have progressively increased from 553 in 2008 to 1,611 
in 2018 [1] (Fig. 1).
Infectious diseases do not respect international borders. 
Especially in this era of globalization and rapid 
international travel, any infectious disease in one country 
can become a potential threat to the entire globe. India 
being a country with massive population and extreme 
geo-climatic diversity, faces a persistent threat of viral 
infections of public health importance. 
The emerging diseases are threat to community as it 
increases morbidity and mortality and even increases 
bioterrorism potential. The categorization of bioterrorist 
agents have been done as A, B and C based on priority 
of agents posing risk and ease with which they can be 
disseminated [2].
One of the challenges in the prevention of outbreak is 
that as the cases decrease, the fear declines, the public 
demand decrease and the mitigation responses get 
overshadowed by the need of emergency responses 
elsewhere. And it is known that if a pathogen is not 
eliminated, it may become endemic. Low socio-
economic status, impoverished environment, lack of 
affordability and accessibility all contribute towards risk 
of infectious disease outbreaks. Poor surveillance system 
and lack of understanding of the diverse epidemiological 
factors necessary for the emergence make control and 
prevention of these outbreaks challenging.
It has been almost a decade since the first PHEIC (Public 
Health Emergency of International Concern) was declared. 
WHO has declared six PHEIC till date-Swine flu in 2009, 
Polio in 2014, Ebola and Zika in 2016, Kivu Ebola in 2019 
and the ongoing 2019-20 coronavirus pandemic [3, 4]. In 
the last decade, various viral diseases have had a serious 
health impact in India. The objective of the current narrative 
review is to explore the various characters of emerging 
infectious disease seen in recent past in India.
Methods
The current narrative article reviews some recent viral 
outbreaks that have occurred in India. The data is 
compiled from World Health Organization (WHO), 
Centre for Disease Control and Prevention (CDC), 
Integrated Disease Surveillance Programme (IDSP), grey 
literature and media. Two of the authors were engaged 
in writing the review article, two in conceptualizing and 
investigating the data and two in validation. Two of them 
were occupied in finding the resources and one author 
did the data curation (Tab. I). The database used are 
scopus, Pubmed and Google scholar.
NIPAH 
The recent outbreak of Nipah in Kerala India had sent 
panic ripples across the world. Nipah virus outbreak was 
The number of outbreaks have progressively increased since many 
years in India. In this era of globalization and rapid international 
travel, any infectious disease in one country can become a poten-
tial threat to the entire globe. Outbreaks of Nipah, Zika, Crimean-
Congo Haemorrhagic Fever and Kyasanur Forest Disease have 
been reported since a decade and now we are facing COVID-19 
pandemic. One of the challenges in the prevention of these out-
breaks is that as the cases decrease, the felt need declines, the 
public demand decreases and the mitigation responses get over-
shadowed by the need of emergency responses elsewhere. The 
One Health approach is a movement to promote alliance between 
medicine field, veterinary medicine and environmental sciences to 
upgrade the health of humans, animals, and ecosystem. The data 
in this article is compiled from different websites and publica-
tions of World Health Organization (WHO), Centre for Disease 
Control and Prevention (CDC), Integrated Disease Surveillance 
Programme (IDSP), grey literature and media. There is an urgent 
need for better surveillance and disease burden assessments in 
the country and to gain detailed insights into vector biology, fac-
tors of environment influencing the diseases, mapping of endemic 
areas, strengthen intersectoral coordination, infection control 
practices, and ensure use of Personal Protective Equipment’s 
(PPE) and availability of drugs and vaccines to handle the out-
breaks in a better way.
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reported on 17th July 2018 in Kozhikode and Malappuram 
districts of Kerala state. A total of 19 cases were seen of 
which 17 died [5] (Fig. 2). 
The causative agent is Nipah virus (family 
Paramyxoviridae) and host being pigs and bats. Nipah 
virus emerged as a new virus 21 years ago i.e. in 1998 
in Malaysia which caused morbidity and deaths and 
demolished the pig-farming industry in Malaysia. This 
virus caused outbreaks in Bangladesh and Siliguri, India 
in 2001 where bats of the Pteropodidae family were 
incriminated as potential reservoirs [6].
Nipah virus outbreak should be suspected in relevant 
epidemiological settings, considering history of travel 
or contact with pigs or bats in patients presenting with 
acute encephalitis. If an outbreak is suspected, the 
animal premises should be quarantined instantly. 
Nipah is classified as category C of bioterrorism potential 
which includes emerging pathogens that could be 
engineered for mass dissemination, are easily produced 
and disseminated, and have capacity for high morbidity 
and mortality rates [7].
Fig. 1. Line graph showing number of reported outbreaks from 2008 to 2018 (source: IDSP, original to the manuscript).
Fig. 2. Graph depicting cases confirmed and died in the reported outbreaks(source: IDSP, original to the manuscript).
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ZIKA
The Zika outbreak has captivated a global audience. 
It is transmitted by mosquito vector and possibly by 
sexual transmission  [8]. On 15th May 2017, Ministry 
of Health and Family Welfare reported 3 laboratory 
confirmed cases of Zika in Bapunagar, Ahmedabad, 
Gujarat [9] (Fig. 2).
Zika virus was first isolated in 1947 in Uganda from a 
rhesus macaque. The first outbreak of Zika virus disease 
has been reported from the Island of Yap, Western Pacific 
region of WHO in 2007. Zika is one of the four PHEIC 
and is unique as it is incriminated in causing congenital 
anomalies [10].
The agent is Zika virus (family Flaviviridae) and host 
are monkeys and humans. There is scientific agreement 
that the Zika virus can cause microcephaly, Guillain–
Barré syndrome (GBS) and other congenital brain 
deformities [11]. In adult cases it is not severe but it can 
have an impact on foetal development and lead to severe 
neurodevelopmental abnormalities. 
KYASANUR FOREST DISEASE (KFD)/ 
MONKEY FEVER
KFD was reported in 2016 in Sindhuburg, Maharashtra, 
India where 488 suspected cases, 130 confirmed cases 
and 3 deaths occurred [12] (Fig. 2).
It was first discovered in 1957 in Kyasanur forest of Shimoga 
district, Karnataka, India. KFD is a public health problem 
along the belts of Western Ghats of India. Deforestation 
results in occupation of shrubs which gives a favourable 
environment to rodents and birds. And these rodents act as 
hosts for the growing larvae and nymphs which increases 
hosts, reservoirs and vector interaction  [13]. To control 
the tick population, forest floor is treated with gamma-
hexachlorocyclohexane. Tick repellents like N, N-diethyl-
meta-toluamide (DEET) and dimethyl phthalate (DMP) 
oil can be used to avoid tick bites. The first vaccine for this 
was made by Indian Council of Medical Research (ICMR) 
that is Russian spring-summer encephalitis virus (RSSEV) 
because of the nearly antigenic resemblance between KFD 
virus and RSSEV [14].
Karnataka state government is following KFD 
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vaccination policy in endemic areas. The vaccine 
is formalin inactivated tissue culture vaccine. It is 
recommended for age group of 5-75 years with a dose of 
1ml for age above 6 years and 0.5 ml below 6. There are 
3 scheduled doses at 0,1,6 months [15].
CRIMEAN-CONGO HAEMORRHAGIC FEVER 
(CCHF) 
First case of CCHF in India was diagnosed in 2011 and 
again the disease re-emerged in 2019 in Gujarat and 
Rajasthan. 5 cases of the disease including 3 deaths in 
Gujarat were reported [16] (Fig. 2).
It was first described in Crimea in 1944. In 1956 the 
pathogen causing Crimean haemorrhagic fever was 
found to be the same as that responsible for an illness 
recognized in Congo, and so it was named as Crimean–
Congo haemorrhagic fever  [17]. It is a serious threat 
for community as well as for health workers mainly in 
countries with poor resources. CCHF and dengue share 
initial clinical features and so it is difficult to diagnose. 
The agent for CCHF is Nairovirus (family Bunyaviridae) 
and host being a range of domestic animals like cattle, 
sheep and goats. Patients with CCHF face bleeding 
from multiple sites as the disease progresses. Several 
case reports recommend that Ribavirin is effective for 
treating CCHF infections [18]. This is the only antiviral 
known to have some effect on the viruses causing viral 
haemorrhagic fever. Health care professionals should 
strictly follow barrier nursing care for undiagnosed 
haemorrhagic fever patients so that nosocomial 
transmission can be prevented  [19]. Tick control 
measures should be used for the tick host and habitat. 
Insecticidal formulations like 0.5% Dichlorovos, 1% 
Carbaryl or 3-5% Malathion can be used on domestic 
animals to get free from ticks [20].
CHANDIPURA VIRUS
The epidemic of Chandipura virus started in June, 
2003. In Andhra Pradesh, 329 children (9 months and 
14 years) developed encephalitis, and the number of 
deaths were 183. The suffering children complained 
of vomiting, abdominal pain, symptoms like Japanese 
encephalitis virus. Chandipura virus was first isolated in 
1965 in a village in Maharashtra, India. It is a member 
of family Rhabdoviridae and is transmitted by vectors 
such as mosquitoes, ticks and sand flies. There is no 
specific treatment available and symptomatic treatment 
is done [21].
JAPANESE ENCEPHALITIS
In Asia, the major cause of viral encephalitis is Japanese 
encephalitis virus. This flavivirus, is possessed by the 
same genus as dengue and yellow fever. The first case of 
Japanese encephalitis viral disease (JE) was registered 
in 1871 in Japan. As the vector population increases in 
rainy season, JE transmission becomes more intense. 
Approximately 1 in 250 cases results in severe clinical 
illness. Safe and effective JE vaccines are available to 
prevent this disease [22].
CORONAVIRUS DISEASE (COVID-19)
An unprecedented outbreak of Corona virus in Wuhan 
City, China emerged in December 2019. The second 
wave has also started in India in 2021. Hospital isolation 
of confirmed cases, contact tracing and home quarantine 
of contacts is ongoing [23, 24].
Discussion
To target the agent, host and environment triad in a better 
way, a concept named One Health approach arrived. The 
One Health approach is a movement to promote alliance 
between medicine field, veterinary medicine and 
environmental sciences to upgrade the health of humans, 
animals, and ecosystem. It is to educate and refine health 
outcomes. This concept of one health is for well being 
of human, animal and plants through a collaborative 
universal approach [25].
In November 2004 Integrated Disease Surveillance 
Project (IDSP) with financial help from World Bank 
commenced disease surveillance system for epidemic 
prone diseases to strengthen decentralized laboratory 
based Information Technology, to detect and respond to 
outbreaks in early phase with the help of Rapid Response 
Teams (RRTs). It presents weekly update on outbreaks 
in the country [26].
Diagnosis of these viruses is possible but is too expensive 
for a cost-effective commercial or routine use. VRC (Viral 
Research Centre) was redesignated as National Institute 
of Virology (NIV) Pune. It is identified today as WHO 
Collaborating Center for arboviruses and haemorrhagic 
fever reference. The centre studies about viral diseases, 
investigates outbreaks and provides diagnosis for viral 
diseases and development of indigenous diagnostic tests.
Vaccination has played a crucial role in reducing 
morbidity and mortality from infectious diseases such 
as in case of Small pox. Vaccines are precious means 
to fight infections and even represents the much wanted 
achievement. But a vaccine takes time to come in public 
due to its side effects and manufacturing problems, 
lack of experimental animal models, faster developing, 
producing and licensing issues. Therefore a new or 
alternative approach in vaccine development is required 
to face pandemic situations [27].
The Department of Health Research (DHR), MOHFW, 
Government of India, in 2013 made a vision to establish 
and strengthen the network of laboratories across 
the country namely Viral Research and Diagnostic 
Laboratory Network (VRDLN). There is a network of 
about 100 laboratories in India with the objectives to 
create infrastructure and identify viruses, for capacity 
building, to develop diagnostics, trainings and meetings 
of health officials and professionals and for research [28].
The most essential aspects of prevention of viral outbreaks 
lies in surveillance of agent, host and environment. WHO 
since long has a mandate for promoting and supervising 
surveillance activities which has been emphasized 
further in recent times as evident from International 
Health Regulations (IHR) and pandemics of Public 
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Health Emergency of International Concern (PHEIC). 
An important limitation of the current review is that 
only the recorded data could be included in this review. 
There could be many other outbreaks which could have 
missed detection or underreported. Thus an essential 
recommendation is the need for a better surveillance and 
disease burden assessments in the country.
Conclusions
The past events strengthen the fact that infectious diseases 
will continue to emerge. If not controlled effectively, 
they will take a devastating toll on human life. There 
is an urgent need for better surveillance and disease 
burden assessments in the country. It is also required to 
gain detailed insights into vector biology, environmental 
factors, mapping of endemic areas, strengthen 
intersectoral coordination, infection control practices, 
and ensure use of Personal Protective Equipment’s 
(PPE) and availability of drugs and vaccines to handle 
the outbreaks in a better way [29].
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